Mt. Sinai Identifies First Drug to Demonstrate Therapeutic Effect in a Type of Autism

Published May 20, 2010 in EurekAlert

Researchers from Mount Sinai School of Medicine have identified a drug that improves communication between nerve cells in a mouse model of Phelan-McDermid Syndrome (PMS). Behavioral symptoms of PMS fall under the autism spectrum disorder category.

http://www.eurekalert.org/pub_releases/2010-05/tmsh-msi052010.php

Filed under: , ,